Carl D. Regillo, MD, FACS, FASRS, discusses geographic atrophy, the advanced stage of dry age-related macular degeneration, including its diagnosis, and progression.
PulseSight Therapeutics submits Clinical Trial Authorization for phase I trial of PST-611
Spotlighting telemedicine in the year of a pandemic
Bausch + Lomb acquires Whitecap Biosciences
City Therapeutics and Bausch + Lomb collaborate on GA treatment candidate
The FDA accepts revised supplemental New Drug Application for IZERVAY
Aviceda Therapeutics completes $207.5 million Series C financing in support of AVD-104 for geographic atrophy treatment